Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis | Science
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library
Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology | Journal of Translational Medicine | Full Text
Frontiers | Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
Epstein Barr Virus Antigen - an overview | ScienceDirect Topics
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine
VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical Diagnostics
Epstein-Barr Virus Infection to Epstein-Barr Virus-Negative Nasopharyngeal Carcinoma Cell Line TW03 Enhances Its Tumorigenicity | Laboratory Investigation
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations | ACS Chemical Neuroscience
Study Of Epstein Barr Virus (Eby) Antibodies: IgG AND lgM Anti -VCA, lgG Anti-Ea and lg Anti-Ebna Obtained with an Original Micr
Detection of Epstein-Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay
Epstein Barr Virus Antigen - an overview | ScienceDirect Topics
Cancer Research and Treatment
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases | Journal of Virology
Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports
Epstein-Barr Virus (VCA) IgG and IgG Avidity ELISA - VIDIA | MoBiTec Molecular Biotechnology
Human Epstein Barr Virus VCA IgA (EBV, VCA IgA) ELISA Test Kit
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
Human Anti-Epstein Barr virus IgG ELISA Kit (EBV-VCA) (ab108730) | Abcam
![PDF] Evaluation of the ARCHITECT EBV VCA IgG, VCA IgM, and EBNA-1 IgG | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/727981ee739144372c7ce7bdece94dd91904779a/16-Table1-1.png "PDF] Evaluation of the ARCHITECT EBV VCA IgG, VCA IgM, and EBNA-1 IgG | Semantic Scholar")
PDF] Evaluation of the ARCHITECT EBV VCA IgG, VCA IgM, and EBNA-1 IgG | Semantic Scholar
PDF) Evaluation of the Architect Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG, VCA IgM, and EBV Nuclear Antigen 1 IgG Chemiluminescent Immunoassays for Detection of EBV Antibodies and Categorization of EBV
Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study | Journal of Kermanshah University of Medical Sciences | Full Text
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink
a) eBV seropositivity rates by age cohorts in a large hospital... | Download Scientific Diagram
Frontiers | Epstein–Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers
